IL148440A0 - Quetiapine granules - Google Patents

Quetiapine granules

Info

Publication number: IL148440A0
Authority: IL; Israel
Prior art keywords: quetiapine granules; quetiapine; granules
Prior art date: 1999-09-21

Application number

IL14844000A

Other languages

English (en)

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-21

Filing date

2000-09-18

Publication date

2002-09-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10861288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL148440(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-09-18 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-09-12 Publication of IL148440A0 publication Critical patent/IL148440A0/xx

Links

239000008187 granular material Substances 0.000 title 1
URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 title 1
229960004431 quetiapine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

IL14844000A 1999-09-21 2000-09-18 Quetiapine granules IL148440A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9922271.3A GB9922271D0 (en)	1999-09-21	1999-09-21	Formulation
PCT/GB2000/003598 WO2001021179A1 (en)	1999-09-21	2000-09-18	Quetiapine granules

Publications (1)

Publication Number	Publication Date
IL148440A0 true IL148440A0 (en)	2002-09-12

Family

ID=10861288

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14844000A IL148440A0 (en)	1999-09-21	2000-09-18	Quetiapine granules
IL148440A IL148440A (en)	1999-09-21	2002-02-27	Quattiapin granules

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL148440A IL148440A (en)	1999-09-21	2002-02-27	Quattiapin granules

Country Status (37)

Country	Link
US (3)	US6599897B1 (de)
EP (1)	EP1218009B1 (de)
JP (1)	JP2003509461A (de)
KR (1)	KR100748823B1 (de)
CN (3)	CN1899288A (de)
AR (1)	AR032596A1 (de)
AT (1)	ATE288272T1 (de)
AU (1)	AU776292B2 (de)
BG (1)	BG65469B1 (de)
BR (1)	BR0014107A (de)
CA (1)	CA2383131A1 (de)
CO (1)	CO5180585A1 (de)
CZ (1)	CZ301585B6 (de)
DE (1)	DE60017923T2 (de)
DK (1)	DK1218009T3 (de)
EE (1)	EE200200150A (de)
EG (1)	EG24226A (de)
ES (1)	ES2235941T3 (de)
GB (2)	GB9922271D0 (de)
HK (1)	HK1047706B (de)
HU (1)	HUP0203531A3 (de)
IL (2)	IL148440A0 (de)
IS (1)	IS2139B (de)
MX (1)	MXPA02002627A (de)
MY (1)	MY130208A (de)
NO (1)	NO320908B1 (de)
NZ (1)	NZ517549A (de)
PL (1)	PL198824B1 (de)
PT (1)	PT1218009E (de)
RU (1)	RU2256453C2 (de)
SI (1)	SI1218009T1 (de)
SK (1)	SK286884B6 (de)
TR (1)	TR200200716T2 (de)
TW (1)	TWI226832B (de)
UA (1)	UA73529C2 (de)
WO (1)	WO2001021179A1 (de)
ZA (1)	ZA200201709B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9922271D0 (en) *	1999-09-21	1999-11-17	Zeneca Ltd	Formulation
SE0102855D0 (sv) *	2001-08-27	2001-08-27	Astrazeneca Ab	Method of treatment
WO2003039516A1 (en) *	2001-11-07	2003-05-15	Fujisawa Pharmaceuticla Co., Ltd.	Method for improving dissolution of poorly dispersible medicaments
JP4514473B2 (ja) *	2004-02-23	2010-07-28	富士通株式会社	コンピュータシステム、中央装置及びプログラム実行方法
US7459469B2 (en)	2004-11-10	2008-12-02	Targacept, Inc.	Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru) *	2004-11-10	2009-11-25	Таргасепт, Інк.	Гидроксибензоатные соли метаникотиновых соединений
US8048876B2 (en)	2005-04-21	2011-11-01	Medichem S.A.	Process for preparing quetiapine and quetiapine fumarate
US20100178333A1 (en)	2006-01-25	2010-07-15	Astron Research Limited	Sustained release dosage form of phenothiazine derivatives containing channelizer
TWI389889B (zh) *	2006-05-09	2013-03-21	Targacept Inc	（２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
US8017785B2 (en) *	2006-05-09	2011-09-13	Astrazeneca Ab	Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine
EP2063876A1 (de) *	2006-07-28	2009-06-03	Farmaprojects, S.A.	Pharmazeutische metoprolol-formulierung mit verlängerter freisetzung und herstellungsverfahren dafür
US20080085888A1 (en) *	2006-09-15	2008-04-10	Breining Scott R	Therapeutic Combinations
WO2008052354A1 (en) *	2006-11-03	2008-05-08	University Of Saskatchewan	Method of treating demyelination diseases
WO2008091592A1 (en) *	2007-01-22	2008-07-31	Targacept, Inc.	Intranasal, buccal, and sublingual administration of metanicotine analogs
DE602007009036D1 (de)	2007-02-14	2010-10-21	Lesvi Laboratorios Sl	Pharmazeutische Zusammensetzungen mit Quetiapinfumarat
CN102014655B (zh) *	2008-02-27	2016-01-13	洲际大品牌有限责任公司	多区糖食
EP2262486B1 (de)	2008-08-01	2013-01-02	KRKA, Tovarna Zdravil, D.D., Novo Mesto	Quetiapin-zusammensetzung
DE102008046650A1 (de)	2008-09-10	2010-03-11	Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg	Quetiapin enthaltende Retardtablette
CN107714703A (zh)	2009-12-31	2018-02-23	凯姆制药公司	喹硫平的氨基酸缀合物、其制备和使用方法
EP3476218A1 (de)	2010-03-11	2019-05-01	Kempharm, Inc.	Fettsäurekonjugate aus quetiapin, verfahren zur herstellung und verwendung davon
US8703802B2 (en)	2010-05-20	2014-04-22	Targacept, Inc.	Process for the preparation of aryl substituted olefinic amines
DE102010033527A1 (de)	2010-08-05	2012-02-09	Acino Pharma Ag	Quetiapin-Tabletten
DE102011115690A1 (de)	2011-10-11	2013-04-11	Acino Pharma Ag	Quetiapin enthaltende Formulierungen
US9993486B1 (en)	2017-06-19	2018-06-12	Tlc Therapeutics, Llc	Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
EP4142735A4 (de) *	2020-04-29	2024-06-19	Stepan Company	Feste zusammensetzungen mit amin-, protonierten amin- oder quaternären ammoniumverbindungen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8607684D0 (en) *	1986-03-27	1986-04-30	Ici America Inc	Thiazepine compounds
GB8705574D0 (en) *	1987-03-10	1987-04-15	Ici Plc	Preparation of thiazepine compound
EP0416773B1 (de) *	1989-08-31	1993-03-03	Takeda Chemical Industries, Ltd.	Vitamin-B12-Zusammensetzung
IT1250701B (it) *	1991-07-24	1995-04-21	Angelini Francesco Ist Ricerca	Composizione farmaceutica solida per uso orale a base di dapiprazolo
JPH06100602A (ja) *	1992-09-18	1994-04-12	Asahi Chem Ind Co Ltd	経口固形製剤およびその製造方法
US5397576A (en) *	1992-09-23	1995-03-14	Hoffmann-La Roche Inc.	Spray triturated micronutrient compositions
KR100313649B1 (ko) *	1992-11-09	2002-02-28	더 부츠 캄파니 피엘씨	신경계질환치료제로서유용한1,4-벤조티아제핀,이의제조방법및이를포함하는약제학적조성물
ZA973433B (en) *	1996-04-24	1997-12-10	Shionogi & Co	A sertindole-containing preparation and a method for producing the same.
US5948437A (en) *	1996-05-23	1999-09-07	Zeneca Limited	Pharmaceutical compositions using thiazepine
GB9611328D0 (en) *	1996-05-31	1996-08-07	Zeneca Ltd	Pharmaceutical compositions
ID21762A (id) *	1996-09-24	1999-07-22	Lilly Co Eli	Formulasi partikel bersaput
US7919119B2 (en) *	1999-05-27	2011-04-05	Acusphere, Inc.	Porous drug matrices and methods of manufacture thereof
GB9922271D0 (en) *	1999-09-21	1999-11-17	Zeneca Ltd	Formulation

1999
- 1999-09-21 GB GBGB9922271.3A patent/GB9922271D0/en not_active Ceased
2000
- 2000-09-01 GB GBGB0021406.4A patent/GB0021406D0/en not_active Ceased
- 2000-09-18 EE EEP200200150A patent/EE200200150A/xx unknown
- 2000-09-18 WO PCT/GB2000/003598 patent/WO2001021179A1/en not_active Ceased
- 2000-09-18 SI SI200030640T patent/SI1218009T1/xx unknown
- 2000-09-18 HU HU0203531A patent/HUP0203531A3/hu unknown
- 2000-09-18 US US10/088,804 patent/US6599897B1/en not_active Expired - Lifetime
- 2000-09-18 PT PT00960855T patent/PT1218009E/pt unknown
- 2000-09-18 NZ NZ517549A patent/NZ517549A/en not_active IP Right Cessation
- 2000-09-18 CZ CZ20020974A patent/CZ301585B6/cs not_active IP Right Cessation
- 2000-09-18 IL IL14844000A patent/IL148440A0/xx active IP Right Grant
- 2000-09-18 DK DK00960855T patent/DK1218009T3/da active
- 2000-09-18 KR KR1020027003676A patent/KR100748823B1/ko not_active Expired - Fee Related
- 2000-09-18 AT AT00960855T patent/ATE288272T1/de active
- 2000-09-18 SK SK372-2002A patent/SK286884B6/sk not_active IP Right Cessation
- 2000-09-18 ES ES00960855T patent/ES2235941T3/es not_active Expired - Lifetime
- 2000-09-18 DE DE60017923T patent/DE60017923T2/de not_active Expired - Lifetime
- 2000-09-18 CA CA002383131A patent/CA2383131A1/en not_active Abandoned
- 2000-09-18 JP JP2001524605A patent/JP2003509461A/ja active Pending
- 2000-09-18 CN CNA2006101007643A patent/CN1899288A/zh active Pending
- 2000-09-18 UA UA2002043283A patent/UA73529C2/uk unknown
- 2000-09-18 AU AU73023/00A patent/AU776292B2/en not_active Ceased
- 2000-09-18 TR TR2002/00716T patent/TR200200716T2/xx unknown
- 2000-09-18 PL PL357369A patent/PL198824B1/pl unknown
- 2000-09-18 MX MXPA02002627A patent/MXPA02002627A/es active IP Right Grant
- 2000-09-18 HK HK02109363.8A patent/HK1047706B/en not_active IP Right Cessation
- 2000-09-18 CN CNB2004101011599A patent/CN1331472C/zh not_active Expired - Lifetime
- 2000-09-18 CN CNB00813166XA patent/CN1188130C/zh not_active Expired - Lifetime
- 2000-09-18 RU RU2002110456/15A patent/RU2256453C2/ru not_active IP Right Cessation
- 2000-09-18 EP EP00960855A patent/EP1218009B1/de not_active Expired - Lifetime
- 2000-09-18 BR BR0014107-0A patent/BR0014107A/pt not_active Application Discontinuation
- 2000-09-19 MY MYPI20004370A patent/MY130208A/en unknown
- 2000-09-19 CO CO00070974A patent/CO5180585A1/es not_active Application Discontinuation
- 2000-09-20 EG EG20001205A patent/EG24226A/xx active
- 2000-09-20 TW TW089119338A patent/TWI226832B/zh not_active IP Right Cessation
- 2000-09-21 AR ARP000104954A patent/AR032596A1/es unknown
2002
- 2002-02-27 IL IL148440A patent/IL148440A/en not_active IP Right Cessation
- 2002-02-28 ZA ZA200201709A patent/ZA200201709B/en unknown
- 2002-03-11 BG BG106509A patent/BG65469B1/bg unknown
- 2002-03-19 IS IS6308A patent/IS2139B/xx unknown
- 2002-03-20 NO NO20021394A patent/NO320908B1/no not_active IP Right Cessation
2003
- 2003-07-25 US US10/627,198 patent/US7022692B2/en not_active Expired - Fee Related
2006
- 2006-01-10 US US11/329,378 patent/US20060159768A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2235941T3 (es)	2005-07-16
BG65469B1 (bg)	2008-09-30
EE200200150A (et)	2003-04-15
PL357369A1 (en)	2004-07-26
IS6308A (is)	2002-03-19
NZ517549A (en)	2003-10-31
NO20021394L (no)	2002-03-20
ATE288272T1 (de)	2005-02-15
CZ301585B6 (cs)	2010-04-21
NO20021394D0 (no)	2002-03-20
TR200200716T2 (tr)	2002-06-21
SI1218009T1 (en)	2005-06-30
PL198824B1 (pl)	2008-07-31
PT1218009E (pt)	2005-05-31
GB0021406D0 (en)	2000-10-18
CN1331472C (zh)	2007-08-15
AU776292B2 (en)	2004-09-02
CN1188130C (zh)	2005-02-09
WO2001021179A1 (en)	2001-03-29
KR20020033186A (ko)	2002-05-04
UA73529C2 (uk)	2005-08-15
CN1626094A (zh)	2005-06-15
BR0014107A (pt)	2002-08-20
MY130208A (en)	2007-06-29
HUP0203531A2 (hu)	2003-02-28
DK1218009T3 (da)	2005-05-09
EG24226A (en)	2008-11-10
BG106509A (en)	2002-12-29
NO320908B1 (no)	2006-02-13
AR032596A1 (es)	2003-11-19
CO5180585A1 (es)	2002-07-30
KR100748823B1 (ko)	2007-08-13
CA2383131A1 (en)	2001-03-29
US6599897B1 (en)	2003-07-29
HK1047706B (en)	2005-06-10
GB9922271D0 (en)	1999-11-17
IL148440A (en)	2007-07-04
US20040228914A1 (en)	2004-11-18
DE60017923T2 (de)	2006-01-12
DE60017923D1 (de)	2005-03-10
ZA200201709B (en)	2003-05-28
AU7302300A (en)	2001-04-24
HK1047706A1 (en)	2003-03-07
JP2003509461A (ja)	2003-03-11
EP1218009B1 (de)	2005-02-02
EP1218009A1 (de)	2002-07-03
US20060159768A1 (en)	2006-07-20
IS2139B (is)	2006-08-15
SK3722002A3 (en)	2002-07-02
TWI226832B (en)	2005-01-21
CN1899288A (zh)	2007-01-24
US7022692B2 (en)	2006-04-04
HUP0203531A3 (en)	2004-12-28
MXPA02002627A (es)	2002-07-30
RU2256453C2 (ru)	2005-07-20
SK286884B6 (sk)	2009-07-06
CZ2002974A3 (cs)	2002-06-12
CN1374867A (zh)	2002-10-16

Legal Events

Date	Code	Title	Description
2007-12-03	FF	Patent granted
2008-01-06	KB	Patent renewed

Publication	Publication Date	Title
IL148440A0 (en)	2002-09-12	Quetiapine granules
DE60018571D1 (en)	2005-04-14	Hernienprothese
DE60008112D1 (en)	2004-03-11	Respiratorisches syncytialvirus replikation inhibitoren
DE60008382D1 (en)	2004-03-25	Respiratorisches syncytialvirus replikation inhibitoren
DE50002490D1 (en)	2003-07-10	Polyester-polyetherblockcopolymere
DE50008011D1 (en)	2004-11-04	Thixotropierungsmittel
DE60018288D1 (en)	2005-03-31	Polyphenylensulfidlegierungszusammensetzung
DE60027722D1 (en)	2006-06-08	Aspartyl-protease inhibitoren
DE50002614D1 (en)	2003-07-24	Sigma-delta-modulator
GB9903584D0 (en)	1999-04-07	Modified calycins
DE60007505D1 (en)	2004-02-05	Propargyletherderivate
DE60028360D1 (en)	2006-07-06	Ptk-chipthermistor
DE60011809D1 (en)	2004-07-29	Oxcarbazepinsuspension
DE50000137D1 (en)	2002-05-16	Spirofluorenopyrane
DE59909975D1 (en)	2004-08-19	Testleck
DE60001313D1 (en)	2003-03-06	Imidazodiazepinderivate
DE10081629D2 (en)	2003-03-13	Seilzugbefestigung
AU140373S (en)	2000-04-12	Bumbag
DE60012950D1 (en)	2004-09-16	Polyacetalharzzusammensetzung
DE50009469D1 (en)	2005-03-17	Common-rail-injektor
AU141428S (en)	2000-08-14	Turnpiece
DE50010757D1 (en)	2005-08-25	Stilbenaufheller
DE50012999D1 (en)	2006-07-27	Stirnwandisolation
DE50008218D1 (en)	2004-11-18	Common-rail-injektor
DE60012212D1 (en)	2004-08-19	Orthotopisches totalkunstherz